NASDAQ: PREPrenetics Global Ltd Stock
$20.60-0.67 (-3.15%)
Updated Oct 14, 2026
PRE Price
$20.60
Fair Value Price
N/A
Market Cap
$355.68M
52 Week Low
$11.37
52 Week High
$27.24
P/E
-7.18x
P/B
3.82x
P/S
2.37x
PEG
N/A
Dividend Yield
N/A
Revenue
$139.29M
Earnings
-$47.00M
Gross Margin
63.8%
Operating Margin
-33.68%
Profit Margin
-33.7%
Debt to Equity
0.65
Operating Cash Flow
N/A
Beta
0.42
Next Earnings
Nov 9, 2026
Ex-Dividend
N/A
Next Dividend
N/A
PRE Overview
Prenetics Global Limited is a consumer health sciences company that has pivoted to focus on a consumer health and longevity platform. The company's main brand is IM8, which offers science-backed nutritional supplements. It also operates CircleDNA, a consumer genetic testing brand that provides personalized health reports based on sequencing technology.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine PRE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
D
PRE
Ranked#25 of 45
Ranked#25 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $62.38 | A | |
| $181.78 | B | |
| $121.84 | B |
Be the first to know about important PRE news, forecast changes, insider trades & much more!
PRE News
Overview
Due Diligence Score
–
Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how PRE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PRE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PRE is poor value based on its book value relative to its share price (3.82x), compared to the US Packaged Foods industry average (1.49x)
P/B vs Industry Valuation
PRE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more PRE due diligence checks available for Premium users.
Valuation
PRE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-7.18x
Industry
9.19x
Market
45.8x
PRE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.82x
Industry
1.49x
PRE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
PRE's financial health
Profit margin
Revenue
$46.5M
Net Income
-$9.0M
Profit Margin
-19.3%
PRE's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$153.7M
Liabilities
$60.7M
Debt to equity
0.65
PRE's short-term assets ($147.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PRE's short-term assets ($147.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PRE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PRE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$15.8M
Investing
$41.7M
Financing
-$22.9M
PRE vs Food Stocks
Prenetics Global Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.